{
    "organizations": [],
    "uuid": "cdbc167b45a7c8d8cec72c3a436610565ef2727b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-merck-kgaa-says-announces-positive/brief-merck-kgaa-says-announces-positive-phase-iib-results-for-evobrutinib-idUSFWN1QP0L8",
    "ord_in_thread": 0,
    "title": "BRIEF-Merck KGaA says announces positive phase IIb results for Evobrutinib",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7 (Reuters) - Merck Kgaa:\n* SAYS ANNOUNCES POSITIVE PHASE IIB RESULTS FOR EVOBRUTINIB IN RELAPSING MULTIPLE SCLEROSIS‍​ Source text: bit.ly/2oOGiKW Further company coverage:\n ",
    "published": "2018-03-07T22:05:00.000+02:00",
    "crawled": "2018-03-08T17:31:53.012+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "merck",
        "kgaa",
        "say",
        "announces",
        "positive",
        "phase",
        "iib",
        "result",
        "evobrutinib",
        "relapsing",
        "multiple",
        "source",
        "text",
        "company",
        "coverage"
    ]
}